LEGISLATIVE BUDGET BOARD

Austin, Texas

FISCAL NOTE, 86TH LEGISLATIVE REGULAR SESSION

March 30, 2019

TO:	Honorable Senfronia Thompson, Chair, House Committee on Public Health
FROM:	John McGeady, Assistant Director     Sarah Keyton, Assistant Director Legislative Budget Board
IN RE:	HB4055 by Wu (Relating to the availability under Medicaid of certain drugs used to treat human immunodeficiency virus and prevent acquired immune deficiency syndrome.), As Introduced

No significant fiscal implication to the State is anticipated.

The bill would prohibit the Health and Human Services Commission (HHSC), or managed care organizations, from requiring certain actions in Medicaid related to dispensing of antiretroviral drugs. According to HHSC, there would be no fiscal impact associated with implementation of the provisions of the bill as they do not differ from current policy.

Local Government Impact

No fiscal implication to units of local government is anticipated.

Source Agencies:

529 Health and Human Services Commission

LBB Staff:

WP, AKi, LR